Whole Genome Amplification Market Increasing Demand, Growth Analysis and Future Outlook by 2031

Global whole genome amplification market is anticipated to grow at a CAGR of 7.3% during the forecast period (2024-2031). Whole genome amplification promotes personalized therapy and enhanced outcomes for patients with chronic diseases by enabling a more precise and thorough investigation of the human genome. Therefore, the growing prevalence of chronic disorders across the globe has created scope for the demand of whole genome amplification kits. Therefore, key kit manufacturers are focusing on manufacturing advanced kits that are useful in treating and diagnosing chronic disorders.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/whole-genome-amplification-market

The introduction of advanced whole genome amplification kits by major market players is likely to drive the global market. For instance, in March 2024, BioSkryb Genomics Inc. launched the new whole genome and transcriptome core kits to accelerate single cell multiomics. The new single-cell core kits leverage the power of primary template-directed amplification (PTA) in an end-to-end kitted workflow that provides amplification and library preparation reagents, sequencing adapters, and the BaseJumper bioinformatics platform. The company's foundational PTA chemistry enables high-resolution single-cell DNA insights with 97.0% genomic coverage and 93% allelic balance. As part of these new kit configurations, total workflow time has been reduced to under eight hours for both products.

Further, in February 2024, Takara Bio announced the plans to launch two critical solutions for oncology research. These automated single-cell total RNA-seq and DNA-seq library preparation kits will provide high sample and cell throughput, less hands-on time, and the ability to capture more information than other available technologies. The Shasta Total RNA-Seq Kit will detect splicing isoforms, gene fusions, and non-polyadenylated RNAs through full-length transcriptome profiling of up to 100,000 single cells per run.

Global Whole Genome Amplification Market Report Segment

By Product Type

Instruments
Kits & Reagents

By Application

Drug Discovery and Development
Disease Diagnosis
Agriculture
Veterinary Research
Forensics
Others (Personalized Medicine)

By End-User

Pharma and Biotech Companies
Contract Research Organizations
Academic Institutes
Others (Hospitals & Clinics)

A full report of Whole Genome Amplification Market available @ https://www.omrglobal.com/industry-reports/whole-genome-amplification-market

Whole Genome Amplification Market Report Segment by Region

North America          

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific   

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Middle East & Africa
Latin America

Company Profiles

23&Me Inc.
Bio-Rad Laboratories, Inc.
Danaher Corp.
Eurofins Scientific SE
Hoffmann-La Roche Ltd.
Luminex Corp.
Merck KGaA
Myriad Genetics Inc.
Oxford Nanopore Technologies
Pacific Biosciences of California Inc.
Perkilenmer Inc.

Reasons to Buying From us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.